IE40043B1 - 16,17,18,19,20-pentanorprostaglandins - Google Patents
16,17,18,19,20-pentanorprostaglandinsInfo
- Publication number
- IE40043B1 IE40043B1 IE2014/73A IE201473A IE40043B1 IE 40043 B1 IE40043 B1 IE 40043B1 IE 2014/73 A IE2014/73 A IE 2014/73A IE 201473 A IE201473 A IE 201473A IE 40043 B1 IE40043 B1 IE 40043B1
- Authority
- IE
- Ireland
- Prior art keywords
- trans
- dimethylisopropylsilyloxy
- pentanor
- indanyl
- cis
- Prior art date
Links
- -1 5,6 - dimethoxy- 2 - indanyl Chemical group 0.000 abstract 4
- 239000007983 Tris buffer Substances 0.000 abstract 2
- YCXVDEMHEKQQCI-UHFFFAOYSA-N chloro-dimethyl-propan-2-ylsilane Chemical compound CC(C)[Si](C)(C)Cl YCXVDEMHEKQQCI-UHFFFAOYSA-N 0.000 abstract 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 abstract 1
- 150000003180 prostaglandins Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0025—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/30—Compounds having groups
- C07C43/315—Compounds having groups containing oxygen atoms singly bound to carbon atoms not being acetal carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C62/30—Unsaturated compounds
- C07C62/34—Unsaturated compounds containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4018—Esters of cycloaliphatic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/54—Quaternary phosphonium compounds
- C07F9/5407—Acyclic saturated phosphonium compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
1456838 Silylated prostaglandins PFIZER Inc 8 Nov 1973 [8 Nov 1972] 51997/73 Heading C3S [Also in Division C2] N - Methansulphonyl - 15 - (5,6 - dimethoxy- 2 - indanyl) - 9α,11α,15# - tris - (dimethylisopropylsilyloxy) - 16,17,18,19,20 - pentanor - 13 - trans-prostenamide is prepared by hydrogenating N-methanesulphonyl-15-(5,6-dimethoxy-2- indanyl) - 9α,11α,15# - tris - (dimethylisopropylsilyloxy) - 16,17,18,19,20 - pentanor - 5 - cis, 13- trans-prostadienamide, resulting from the reaction between dimethylisopropylchlorosilane and N - methanesulphonyl - 9α,11α,15# - trihydroxy - 16,17,18,19,20 - pentanor - 5 - cis, 13- trans - prostadienamide. 16 - (2 - Indonyl)- 11α,15α - bis - (dimethylisopropylsilyloxy) - 9- oxo - 17,18,19,20 - tetranor - 13 - trans - prostenoic acid and 16-(2-indanyl)-11α,15α-bis-(dimethylisopropylsilyloxy) - 9 - oxo - 17,18.19,20- tetranor-5-cis, 13-trans-prostadienoic acid are obtained in a similar manner.
[GB1456838A]
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IE101/77A IE40044B1 (en) | 1972-11-08 | 1973-11-08 | Cyclopentane derivatives |
IE102/77A IE40045B1 (en) | 1972-11-08 | 1973-11-08 | Substituted dimethyl oxophosphonates |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30475072A | 1972-11-08 | 1972-11-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
IE40043L IE40043L (en) | 1974-05-08 |
IE40043B1 true IE40043B1 (en) | 1979-02-28 |
Family
ID=23177829
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE2014/73A IE40043B1 (en) | 1972-11-08 | 1973-11-08 | 16,17,18,19,20-pentanorprostaglandins |
Country Status (20)
Country | Link |
---|---|
JP (1) | JPS5714347B2 (en) |
AT (1) | AT345999B (en) |
BE (1) | BE807046A (en) |
CA (1) | CA1033727A (en) |
CH (1) | CH593930A5 (en) |
DE (1) | DE2355731C3 (en) |
DK (1) | DK143499C (en) |
ES (3) | ES420386A1 (en) |
FI (1) | FI58912C (en) |
FR (3) | FR2205338B1 (en) |
GB (1) | GB1456838A (en) |
IE (1) | IE40043B1 (en) |
IL (2) | IL50310A (en) |
IN (1) | IN139265B (en) |
NL (1) | NL7315307A (en) |
NO (2) | NO143663C (en) |
PH (2) | PH13261A (en) |
SE (4) | SE412229B (en) |
SU (2) | SU667131A3 (en) |
ZA (1) | ZA738595B (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1431561A (en) * | 1973-01-31 | 1976-04-07 | Ici Ltd | Cyclopentane derivatives |
US3929862A (en) * | 1974-01-08 | 1975-12-30 | Upjohn Co | Substituted tolylesters of PGF{HD 2{B {60 |
JPS5823393B2 (en) * | 1974-03-14 | 1983-05-14 | オノヤクヒンコウギヨウ カブシキガイシヤ | prostaglandin |
US4028396A (en) * | 1975-07-02 | 1977-06-07 | American Cyanamid Company | 16,16-Spirocycloalkyl prostaglandin derivatives |
NZ183136A (en) * | 1976-02-11 | 1978-11-13 | Miles Lab | Monospiroalkyl derivatives of prostaclandis and pharmaceutical compositions |
US4074063A (en) * | 1976-02-11 | 1978-02-14 | Miles Laboratories, Inc. | Bicycloalkyl derivatives of prostaglandins |
US4404372A (en) * | 1977-06-13 | 1983-09-13 | Pfizer Inc. | 15-Substituted-ω-pentanorprostaglandin derivatives |
DE2753995A1 (en) * | 1977-12-03 | 1979-06-07 | Bayer Ag | NEW BICYCLOALKENYL PROSTAGLANDINS AND THE METHOD OF MANUFACTURING THEM |
ATE270660T1 (en) * | 1997-09-09 | 2004-07-15 | Univ Duke | AROMATIC C16-C20-SUBSTITUTED TETRAHYDRO-PROSTAGLANDINS USABLE LIKE FP AGONISTS |
AU741014B2 (en) * | 1997-09-09 | 2001-11-22 | Duke University | Aromatic C16-C20-substituted tetrahydro prostaglandins useful as FP agonists |
ATE227266T1 (en) * | 1997-09-09 | 2002-11-15 | Procter & Gamble | AROMATIC C16-C20-SUBSTITUTED TETRAHYDRO-PROSTAGLANDINS AND THEIR USE AS PROSTAGLANDIN F AGONISTS |
CA2364948C (en) | 1999-03-05 | 2011-04-26 | The Procter & Gamble Company | C16 unsaturated fp-selective prostaglandins analogs |
US20020013294A1 (en) | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
US20020172693A1 (en) | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
US20020037914A1 (en) | 2000-03-31 | 2002-03-28 | Delong Mitchell Anthony | Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
DE502007000840D1 (en) * | 2007-11-28 | 2009-07-16 | Bauer Maschinen Gmbh | winch |
US8722739B2 (en) | 2008-10-29 | 2014-05-13 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
US8623918B2 (en) | 2008-10-29 | 2014-01-07 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
US20230097470A1 (en) * | 2021-08-23 | 2023-03-30 | Chirogate International Inc. | Processes and intermediates for the preparations of carboprost and carboprost tromethamine, and carboprost tromethamine prepared therefrom |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4864073A (en) * | 1971-04-30 | 1973-09-05 |
-
1973
- 1973-11-05 IL IL50310A patent/IL50310A/en unknown
- 1973-11-05 IL IL43571A patent/IL43571A/en unknown
- 1973-11-06 SE SE7315074A patent/SE412229B/en unknown
- 1973-11-08 PH PH15197A patent/PH13261A/en unknown
- 1973-11-08 CH CH1570773A patent/CH593930A5/xx not_active IP Right Cessation
- 1973-11-08 BE BE1005488A patent/BE807046A/en unknown
- 1973-11-08 GB GB5199773A patent/GB1456838A/en not_active Expired
- 1973-11-08 NO NO4294/73A patent/NO143663C/en unknown
- 1973-11-08 IE IE2014/73A patent/IE40043B1/en unknown
- 1973-11-08 AT AT941073A patent/AT345999B/en not_active IP Right Cessation
- 1973-11-08 FR FR7339758A patent/FR2205338B1/fr not_active Expired
- 1973-11-08 JP JP12584373A patent/JPS5714347B2/ja not_active Expired
- 1973-11-08 DE DE2355731A patent/DE2355731C3/en not_active Expired
- 1973-11-08 FI FI3455/73A patent/FI58912C/en active
- 1973-11-08 CA CA185,366A patent/CA1033727A/en not_active Expired
- 1973-11-08 DK DK603373A patent/DK143499C/en active
- 1973-11-08 NL NL7315307A patent/NL7315307A/xx not_active Application Discontinuation
- 1973-11-08 ZA ZA738595A patent/ZA738595B/en unknown
- 1973-11-09 ES ES420386A patent/ES420386A1/en not_active Expired
- 1973-11-23 IN IN2583/CAL/73A patent/IN139265B/en unknown
- 1973-12-07 SU SU731978255A patent/SU667131A3/en active
-
1974
- 1974-10-07 NO NO743616A patent/NO144385C/en unknown
-
1975
- 1975-12-23 SU SU752182652A patent/SU704456A3/en active
-
1976
- 1976-01-16 ES ES444398A patent/ES444398A1/en not_active Expired
- 1976-01-29 FR FR7602433A patent/FR2286147A1/en active Granted
- 1976-01-29 FR FR7602434A patent/FR2291200A1/en active Granted
- 1976-05-25 PH PH18469A patent/PH13320A/en unknown
- 1976-11-03 SE SE7612261A patent/SE7612261L/en unknown
- 1976-11-03 SE SE7612262A patent/SE7612262L/en not_active Application Discontinuation
-
1977
- 1977-02-10 SE SE7701523A patent/SE417957B/en unknown
- 1977-11-25 ES ES456279A patent/ES456279A1/en not_active Expired
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IE40043B1 (en) | 16,17,18,19,20-pentanorprostaglandins | |
GB1409841A (en) | Prostaglandins and the manufacture thereof | |
GB1448413A (en) | Prostaglandins and the manufacture therof | |
AU468059B2 (en) | Mutanase, an alpha-1, 3-glucanese, a process forthe preparation thereof aswell ascertain uses ofthe said mutanese | |
ES444045A1 (en) | Prostanoic acid derivatives | |
CA1018171A (en) | SUBSTITUTED .alpha.-AMINOOXYCARBOXYLIC ACID HYDRAZIDE DERIVATIVES AND A PROCESS FOR THE PREPARATION THEREOF | |
IE37909B1 (en) | 15-substituted-omega-pentanorprostaglandins | |
CA1031374A (en) | Manufacture of 1,6-hexanediol | |
CA1014490A (en) | Light-weight, flexible, easy-open, impermeable package system | |
CA1028699A (en) | Prostanoic acid derivatives | |
AU473283B2 (en) | 8,12 prostaglandin analogues | |
IE41600L (en) | 3, 4 - dihydro - 2h - isoquinolin - 1 - thiones | |
CA1033752A (en) | 2,3-disubstituted 7-oxabicyclo-(2.2.1)-5-heptene derivatives | |
GB1450425A (en) | Process for the manufacture of beta-3-oxo-7alpha-acetylthio- 17beta-hydroxy-4-androsten-17alpha-yl- -propionic acid ypsilon- lactone and an intermediate in its production | |
IE40177L (en) | D-homopregnenes. | |
CA967565A (en) | Selective reduction of 9,15-diketo prostaglandins | |
IE37977B1 (en) | Norbornane derivatives | |
CA968792A (en) | Stereospecific reduction of 9,15-diketo prostaglandins | |
GB1397431A (en) | Insecticidal steroid | |
CA1028352A (en) | PREPARATION OF .alpha.,3-DICHLORO-4-CYCLOHEXYLPHENYL-ACETIC ACID | |
CA1028351A (en) | PREPARATION OF .alpha.,3-DICHLORO-4-CYCLOHEXYLPHENYL-ACETIC ACID | |
IE40108B1 (en) | Substituted s-triazino-(1,2)-benzimidazoles and their manufacture | |
IE39500L (en) | Citric acid production and intermediate therefor. | |
CA1022183A (en) | 1,4-diacyloxy-2,3-butanediol and a method for its producing | |
AU485558B2 (en) | N, n'disubstituted naphthaleneacetamidines |